News/Events

News

Biovac in talks to make COVID-19 vaccine

20 Nov 2020

 Biovac has the capacity to manufacture between 20-m and 30-m Covid-19 vaccines a year, depending on the technology involved. This is a fraction of the 300-m annual doses of Johnson & Johnson’s Covid-19 vaccine that Aspen plans to manufacture at its facility in Port Elizabeth.

[BACK TO NEWS]